For people with anxiety and depression, these conditions can feel like two sides of the same coin. Researchers are exploring ...

Even individuals whose symptoms do not yet meet the criteria for clinical depression benefit from therapeutic interventions. This conclusion comes from a new meta-study by researchers who analyzed ...

Study of 5 million people of all backgrounds finds variations in hundreds of genes; previous studies were on people of ...

MYND Life Sciences (CSE: MYND) (OTC Pink: MYNDF) ("MYND" or the "Company") a clinical-stage life sciences company committed ...

Autobahn Therapeutics, a biotechnology company developing restorative treatments for people affected by neuropsychiatric and neuroimmunologic disorders, today announced the initiation of a Phase 2 ...

Even individuals whose symptoms do not yet meet the criteria for clinical depression benefit from therapeutic interventions.

Depression can affect anyone. It is common, and in many cases severe. These days, there are good treatments available, typically involving a combination of psychotherapy and medication. However, ...

Two studies show positive treatment effect and improved quality of life among patients with treatment-resistant depression.

New research has revealed nearly 300 previously unknown genetic links to depression, in the world’s largest and most diverse ...

New genetic risk factors for depression have been identified across all major global populations for the first time, allowing scientists to predict risk of depression regardless of ethnicity. The ...

New genetic risk factors for depression have been identified across all major global populations for the first time, allowing scientists to predict risk of depression regardless of ethnicity.

Many Canadians struggle with SAD, a real form of depression that can make navigating the winter months extremely difficult.